Source: International journal of surgery. Unidade: FM
Subjects: NEOPLASIAS ESOFÁGICAS, TERAPIA COMBINADA, CARCINOMA DE CÉLULAS ESCAMOSAS, METANÁLISE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTA, F. C. et al. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options. International journal of surgery, v. 54, p. 176-181, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ijsu.2018.04.053. Acesso em: 09 out. 2024.APA
Mota, F. C., Cecconello, I., Takeda, F. R., Tustumi, F., Sallum, R. A. A., & Bernardo, W. M. (2018). Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options. International journal of surgery, 54, 176-181. doi:10.1016/j.ijsu.2018.04.053NLM
Mota FC, Cecconello I, Takeda FR, Tustumi F, Sallum RAA, Bernardo WM. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options [Internet]. International journal of surgery. 2018 ; 54 176-181.[citado 2024 out. 09 ] Available from: https://doi.org/10.1016/j.ijsu.2018.04.053Vancouver
Mota FC, Cecconello I, Takeda FR, Tustumi F, Sallum RAA, Bernardo WM. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options [Internet]. International journal of surgery. 2018 ; 54 176-181.[citado 2024 out. 09 ] Available from: https://doi.org/10.1016/j.ijsu.2018.04.053
